Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review
出版年份 2023 全文链接
标题
Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review
作者
关键词
-
出版物
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-03-03
DOI
10.1007/s00787-023-02169-w
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Fragile X Syndrome: From Molecular Aspect to Clinical Treatment
- (2022) Dragana D. Protic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review
- (2021) Corneliu N. Stanciu et al. PSYCHIATRIC SERVICES
- Cannabis use in adolescence and risk of psychosis: Are there factors that moderate this relationship? A systematic review and meta-analysis
- (2021) Sarah Kanana Kiburi et al. Substance Abuse
- Cannabinoid treatment for autism: a proof-of-concept randomized trial
- (2021) Adi Aran et al. Molecular Autism
- Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial
- (2021) Jesper Østrup Rasmussen et al. BMC Psychiatry
- Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions
- (2021) Joshua D. Brown et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: A systematic review and meta-analysis of randomised controlled trials
- (2021) Kyle A. McKee et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Environmental Risk Factors for Schizophrenia and Bipolar Disorder and Their Relationship to Genetic Risk: Current Knowledge and Future Directions
- (2021) Natassia Robinson et al. Frontiers in Genetics
- Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder
- (2021) Majd Al-Soleiti et al. JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS
- Don’t make a hash of it! A thematic review of the literature relating to outcomes of cannabis regulatory change
- (2021) Karen Oldfield et al. DRUGS-EDUCATION PREVENTION AND POLICY
- Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis
- (2021) Nir Treves et al. Scientific Reports
- Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
- (2020) Jerome Sarris et al. BMC Psychiatry
- News Feature: Cannabis and the adolescent brain
- (2020) Helen Shen PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials
- (2020) Rafael G. Dos Santos et al. Expert Opinion on Drug Metabolism & Toxicology
- Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome
- (2020) Kirsten R. Müller-Vahl et al. NEUROPSYCHOPHARMACOLOGY
- Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions
- (2020) Joshua D. Brown Journal of Clinical Medicine
- Efficacy and acceptability of cannabinoids for anxiety disorders in adults: a systematic review & meta-analysis
- (2020) Anees Bahji et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties
- (2020) Lara Sharpe et al. Journal of Translational Medicine
- Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence
- (2020) Grace Blest-Hopley et al. Frontiers in Psychiatry
- Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies
- (2020) Laura Fusar-Poli et al. Brain Sciences
- The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
- (2020) Gin S Malhi et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy
- (2019) Lihi Bar-Lev Schleider et al. Scientific Reports
- Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities
- (2019) Dana Barchel et al. Frontiers in Pharmacology
- Lower circulating endocannabinoid levels in children with autism spectrum disorder
- (2019) Adi Aran et al. Molecular Autism
- Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood
- (2019) Gabriella Gobbi et al. JAMA Psychiatry
- How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review
- (2019) Eva Hoch et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Influence of Δ9-tetrahydrocannabinol on long-term neural correlates of threat extinction memory retention in humans
- (2019) Mira Z. Hammoud et al. NEUROPSYCHOPHARMACOLOGY
- Cannabinoid Regulation of Fear and Anxiety: an Update
- (2019) Eleni P. Papagianni et al. Current Psychiatry Reports
- Measuring Disturbance of the Endocannabinoid System in Psychosis
- (2019) Amedeo Minichino et al. JAMA Psychiatry
- Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
- (2019) Joshua D. Brown et al. Journal of Clinical Medicine
- A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome
- (2019) Helen Heussler et al. Journal of Neurodevelopmental Disorders
- Cannabidiol (CBD) use in psychiatric disorders: A systematic review
- (2019) Stefania Bonaccorso et al. NEUROTOXICOLOGY
- Current state of evidence of cannabis utilization for treatment of autism spectrum disorders
- (2019) Rumi Agarwal et al. BMC Psychiatry
- Modulation of the Endocannabinoid and Oxytocinergic Systems as a Potential Treatment Approach for Social Anxiety Disorder
- (2019) Rafael Guimarães Dos Santos et al. CNS DRUGS
- Effects of CBD-Enriched Cannabis sativa Extract on Autism Spectrum Disorder Symptoms: An Observational Study of 18 Participants Undergoing Compassionate Use
- (2019) Paulo Fleury-Teixeira et al. Frontiers in Neurology
- Cannabidiol as a Treatment for Mood Disorders: A Systematic Review
- (2019) Jairo Vinícius Pinto et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence
- (2018) Emily Stockings et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Medical cannabis for paediatric developmental-behavioural and psychiatric disorders
- (2018) Daryl Efron et al. JOURNAL OF PAEDIATRICS AND CHILD HEALTH
- Plasma anandamide concentrations are lower in children with autism spectrum disorder
- (2018) Debra S. Karhson et al. Molecular Autism
- Medication Adherence Among Children and Adolescents with Severe Mental Illness: A Systematic Review and Meta-AnalysisA preliminary version of this study was presented as an abstract at the American Academy of Child and Adolescent Psychiatry's 64th Annual Meeting, Washington DC, October 23–28, 2017.
- (2018) Juliet Beni Edgcomb et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Efficacy of cannabinoids in paediatric epilepsy
- (2018) Shayma Ali et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Cannabidiol as a suggested candidate for treatment of autism spectrum disorder
- (2018) Shani Poleg et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients
- (2017) Ewgeni Jakubovski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Preliminary Evidence on Cannabis Effectiveness and Tolerability for Adults With Tourette Syndrome
- (2017) Elia Abi-Jaoude et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Medication prescribed by Australian paediatricians: Psychotropics predominate
- (2017) Daryl Efron et al. JOURNAL OF PAEDIATRICS AND CHILD HEALTH
- Medical Cannabinoids in Children and Adolescents: A Systematic Review
- (2017) Shane Shucheng Wong et al. PEDIATRICS
- A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders
- (2017) Keane Lim et al. Clinical Psychopharmacology and Neuroscience
- Gilles de la Tourette syndrome
- (2017) Mary M. Robertson et al. Nature Reviews Disease Primers
- Severe motor and vocal tics controlled with Sativex®
- (2016) David Trainor et al. Australasian Psychiatry
- Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex—Possible involvement of 5-HT1A and CB1 receptors
- (2016) A.G. Sartim et al. BEHAVIOURAL BRAIN RESEARCH
- Endocannabinoid Signaling Regulates Sleep Stability
- (2016) Matthew J. Pava et al. PLoS One
- Fetal alcohol spectrum disorder: a guideline for diagnosis across the lifespan
- (2015) Jocelynn L. Cook et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
- (2015) Matthew W. Elmes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The endocannabinoid system in guarding against fear, anxiety and stress
- (2015) Beat Lutz et al. NATURE REVIEWS NEUROSCIENCE
- Endocannabinoid Signaling in Autism
- (2015) Bhismadev Chakrabarti et al. Neurotherapeutics
- Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics
- (2015) Barbara S. Koppel Neurotherapeutics
- Cannabidiol as a Potential Treatment for Anxiety Disorders
- (2015) Esther M. Blessing et al. Neurotherapeutics
- The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study
- (2015) Rakesh Jetly et al. PSYCHONEUROENDOCRINOLOGY
- Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study
- (2015) Rory Sheehan et al. BMJ-British Medical Journal
- Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study
- (2015) Rory Sheehan et al. BMJ-British Medical Journal
- Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology
- (2014) B. S. Koppel et al. NEUROLOGY
- Alterations in the endocannabinoid system in the rat valproic acid model of autism
- (2013) D.M. Kerr et al. BEHAVIOURAL BRAIN RESEARCH
- Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study
- (2013) A Neumeister et al. MOLECULAR PSYCHIATRY
- Targeting the endocannabinoid system in the treatment of fragile X syndrome
- (2013) Arnau Busquets-Garcia et al. NATURE MEDICINE
- Cannabinoid modulation of prefrontal–limbic activation during fear extinction learning and recall in humans
- (2013) Christine A. Rabinak et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks
- (2013) Matthew N. Hill et al. PSYCHONEUROENDOCRINOLOGY
- Baseline Factors Predicting Placebo Response to Treatment in Children and Adolescents With Autism Spectrum Disorders
- (2013) Bryan H. King et al. JAMA Pediatrics
- Multiple Functions of Endocannabinoid Signaling in the Brain
- (2012) István Katona et al. Annual Review of Neuroscience
- Neurocircuitry models of posttraumatic stress disorder and beyond: A meta-analysis of functional neuroimaging studies
- (2012) Ronak Patel et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome
- (2012) Kwang-Mook Jung et al. Nature Communications
- Effects of endocannabinoid system modulation on cognitive and emotional behavior
- (2011) Claudio Zanettini Frontiers in Behavioral Neuroscience
- Oral Δ9-Tetrahydrocannabinol Improved Refractory Gilles de la Tourette Syndrome in an Adolescent by Increasing Intracortical Inhibition
- (2010) Alkomiet Hasan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
- (2009) TV Zanelati et al. BRITISH JOURNAL OF PHARMACOLOGY
- The psychiatric side-effects of rimonabant
- (2009) Fabrício A. Moreira et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Cannabidiol was ineffective for manic episode of bipolar affective disorder
- (2008) AW Zuardi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- FAAH and anandamide: is 2-AG really the odd one out?
- (2008) Vincenzo Di Marzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started